SOURCE: Fast Track Systems

March 08, 2007 14:00 ET

Fast Track Systems Finds Increases in Global Clinical Study Cost and Complexity

CONSHOHOCKEN, PA -- (MARKET WIRE) -- March 8, 2007 -- Fast Track Systems, Inc., a provider of global clinical trial cost benchmarks and study design tools, announces findings from a retrospective analysis of industry protocol design and grant spending which identified a significant increase in the cost and complexity of clinical studies throughout the world over the last five years.

Lori Shields, Fast Track Systems Vice President of Operations, summarized the findings stating: "From 2000 to 2005, the amount that sponsors paid U.S. research sites per subject for Phase II and III trials increased by 42%. During the same period, the complexity of these clinical studies, as measured by the total number of procedures performed, increased by 49%. Comparatively, the rest of the world, excluding the U.S., saw costs increase by 43% and complexity by 60%." This analysis of Fast Track's PICAS database appears in the March 2007 issue of the Journal of Clinical Research Best Practices: (

Fast Track Systems will be exhibiting at the upcoming DIA EuroMeeting in Vienna, Austria (March 25-28, Booth 516) and at the Partnerships with CROs meeting in Orlando, Florida (April 10-12, Booth 215). Individuals from senior management will be in attendance to discuss these findings with interested parties.

About Fast Track Systems, Inc.

Fast Track's products reduce cost, increase compliance, and improve productivity by solving problems associated with the operational aspects of clinical trial design and execution. TrialSpace Designer is the first comprehensive standards-based e-Protocol solution capable of capturing study design information as reusable data that can be seamlessly utilized by other clinical systems and the FDA. Grants Manager and CROCAS draw from over 25,000 finalized protocols, 250,000 negotiated grants, and 4,500 CRO contracts to ensure that subscribers understand the true cost and compliance consequences when negotiating clinical agreements. Visit for more information about our products and services.

Contact Information